2
P. Lundemo et al. / Journal of Molecular Catalysis B: Enzymatic 108 (2014) 1–6
Thermotoga neapolitana (TnBgl3B), is used. It belongs to the glyco-
side hydrolase family 3 and has been reported to have very low
activity in micro-aqueous media, when no enzyme preparation
method was used [16]. In contrast, ˇ-glycosidase from P. furio-
sus, belonging to glycoside hydrolase family 1, has been shown
to be most active in absence of a separate aqueous phase [7]. To
side hydrolase families, Thermotoga neapolitana enzymes from both
families are studied in parallel. For lipases, up to 400-fold activation
has been demonstrated by selecting a proper enzyme preparation
method [17], but to the best of our knowledge, no such attempt has
previously been made for ˇ-glycosidases.
The glycosidases were diluted up to 1 ml in 0.1 M citrate phos-
phate buffer, pH 5.6 to roughly 0.25–0.30 mg/ml and centrifuged
to remove insoluble residues. The supernatants were immediately
2.5. Surfactant modification
A reverse micellar system was created according to a previ-
ously described method [20]. 150 l suspensions of 0.6–0.85 mg/ml
glycosidase in 0.1 M citrate phosphate buffer, pH 5.6 was added
to 5 ml 100 mM dioctyl sodium sulfosuccinate (AOT) in 2,2,4-
trimethylpentane and shaken vigorously. The trimethylpentane
was removed by rotary evaporation and the residue was further
dried in a vacuum desiccator.
2. Materials and methods
2.1. Material
2.6. Factorial immobilization test
Hexyl-ˇ-d-glucoside (HG), p-nitrophenol (pNP) and p-
The influence of buffer strength, pH and incubation time for
adsorption and covalent immobilization of TnBgl1A and TnBgl3B
on the supports listed in sections 2.7 and 2.8 was tested using a 23
factorial design. The software Minitab® (Release 14.1) was used to
evaluate the data. Three factors were studied (buffer strength 0.05,
0.15 and 0.25 mM; buffer pH 4, 5.5 and 7 and incubation time 1,
7 and 24 h). Two replicates and 4 central points was used giving a
total number of 20 runs per enzyme.
nitrophenol-ˇ-d-glucoside
(pNPG)
were
obtained
from
Sigma–Aldrich (St Louis, Missouri, USA) and all other chemicals
from VWR International (Stockholm, Sweden).
2.2. Mutagenesis
The genes encoding TnBgl1A and TnBgl3B were previously
cloned into PET22b(+) (Novagen, Madison, WI, USA) [16,18].
kit (Stratagene, La Jolla, CA), with the sequence with GenBank
accession number AF039487 as the template and the primer
5ꢀ-GGAAAGATAGGGATTGTTTTCTTCAACGGATACTTCGAACCTGC-3ꢀ
[10]. The resulting plasmid was transformed into Escherichia coli
Nova Blue cells for storage and into E. coli BL21 (Novagen) for
expression. The complete gene was sequenced by GATC Biotech
AG (Konstanz, Germany) to confirm the mutations.
2.7. Adsorption
Both glycosidases were immobilized by adsorption to
a
hydrophobic support (Accurel MP-1000) and an anion-exchange
resin (IRA-400). 7 ml 0.09–0.11 mg/ml enzyme in 0.1 mM citrate
phosphate buffer, pH 5.6 was added to 400 mg Accurel MP-1000,
which was pre-wetted with 3 ml ethanol/g support, and to 400 mg
IRA-400, which was pre-washed with 0.1 mM citrate phosphate
buffer, pH 5.6. The enzyme and support was incubated on a nutat-
ing mixer overnight and thereafter filtered and washed with buffer.
Finally, the preparations were dried in a vacuum desiccator. For the
MP-1000 support, a milder drying technique previously described
by Moore et al. was also evaluated [21]. After removing the aque-
ous enzyme solution, the support was washed three times with
n-propanol, the same volume as the original aqueous solution, set
to the desired water activity. This was followed by two washes with
the same volume of hexanol, set to the desired water activity. The
hexanol was removed immediately prior to addition of substrate.
2.3. Expression and purification
The enzymes were synthesized in 0.5 L cultivations of E. coli BL21
(Novagen) in Erlenmeyer flasks at 37 ◦C, pH 7 in Luria-Bertania
(LB) media containing 100 g/ml Ampicillin, inoculated with 1%
over night precultures. After reaching an OD620 of 0.6 TnBgl1A and
TnBgl3B gene expression was induced by addition of 0.5 ml 100 mM
isopropyl-ˇ-d-1-thiogalactopyranoside (IPTG) and production was
continued for 20 h. Cells were harvested by centrifugation for
10 min (4 ◦C, 5500 × g), re-suspended in binding buffer (20 mM
imidazole, 20 mM Tris–HCl, 0.75 M NaCl, pH 7.5) and lysed by son-
ication 6 × 3 min at 60% amplitude and a cycle of 0.5 using a 14 mm
titanium probe (UP400 S, Dr. Hielscher). Heat treatment (70 ◦C,
30 min) and centrifugation (30 min, 4 ◦C, 15,000 × g) was used to
remove most of the native E. coli proteins before purification by
immobilized metal affinity chromatography using an ÄKTA prime
system (Amersham Biosciences, Uppsala, Sweden). The protein
slurry was applied to a Histrap FF crude column (GE Healthcare)
pretreated with 0.1 M Copper (II) sulphate. Bound proteins were
eluted using elution buffer (250 mM imidazole, 20 mM Tris–HCl,
0.75 M NaCl, pH 7.5). Fractions containing protein were pooled
and dialyzed against 50 mM citrate phosphate buffer, pH 5.6, over
night using a 3500 Da molecular weight cut-off dialysis membrane
(Spectrum laboratories, Rancho Dominguez, CA, USA) and stored
at −20 ◦C until use. Purity of the expressed proteins was estimated
using SDS-PAGE according to Laemmli [19].
2.8. Covalent immobilization
400 mg epoxy-activated matrix, Eupergit® C250L, was washed
with 0.1 mM citrate phosphate buffer, pH 5.6. 7 ml 0.09–0.11 mg/ml
enzyme in 0.1 mM citrate phosphate buffer, pH 5.6 was added, incu-
bated on a nutating mixer overnight and thereafter filtered, washed
with buffer and dried in a vacuum desiccator.
2.9. Protein determination
Total protein concentration was estimated at 595 nm by the
Bradford method [22] using bovine serum albumin as standard.
2.10. Water activity
Substrate solutions (34 mM pNPG in hexanol) were incubated
over saturated salt solutions to defined water activities. The salts
used for equilibration were KCH3CO2 (aw = 0.23), MgCl2 (aw = 0.33),
Mg(NO3)2 (aw = 0.53), NaCl (aw = 0.75), KCl (aw = 0.84) and K2SO4